2. Cell Cycle/DNA Damage Epigenetics Autophagy Apoptosis
  3. HDAC Autophagy Apoptosis
  4. HDAC-IN-36

HDAC-IN-36 (compound 23 g) is an orally active and potent HDAC (histone deacetylase) inhibitor, with an IC50 of 11.68 nM (HDAC6). HDAC-IN-36 promotes apoptosis, autophagy and suppresses migration. HDAC-IN-36 shows anti-tumor and anti-metastatic activity, and can be used for breast cancer research.

For research use only. We do not sell to patients.

HDAC-IN-36 Chemical Structure

HDAC-IN-36 Chemical Structure

CAS No. : 2482992-54-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

HDAC-IN-36 Related Antibodies

Top Publications Citing Use of Products

View All HDAC Isoform Specific Products:

View All Isoforms
HDAC HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 HDAC10 HDAC11 HD1 HD2

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

HDAC-IN-36 (compound 23 g) is an orally active and potent HDAC (histone deacetylase) inhibitor, with an IC50 of 11.68 nM (HDAC6). HDAC-IN-36 promotes apoptosis, autophagy and suppresses migration. HDAC-IN-36 shows anti-tumor and anti-metastatic activity, and can be used for breast cancer research[1].

IC50 & Target

HDAC6

11.68 nM (IC50)

HDAC10

13.24 nM (IC50)

HDAC3

79.17 nM (IC50)

HDAC1

86.93 nM (IC50)

HDAC2

97.32 nM (IC50)

HDAC8

378.2 nM (IC50)

HDAC4

>1000 nM (IC50)

HDAC5

>1000 nM (IC50)

HDAC7

>1000 nM (IC50)

HDAC9

>1000 nM (IC50)

HDAC11

>1000 nM (IC50)

In Vitro

HDAC-IN-36 (compound 23 g) (0-10, 24 h) exhibits good antiproliferative activity in MDA-MB-231 cells, promotes the acetylation of α-Tubulin and HSP90[1].
HDAC-IN-36 (0-10, 24 h) induces apoptosis in MDA-MB-231 cells in a dose-dependent manner, and mainly induces mitochondrial-dependent apoptosis[1].
HDAC-IN-36 (0-10, 24 h) inhibits MDA-MB-231 cells migration in a dose-dependent manner, increases the expression of E-cadherin and decreases the expression of MMP-2 obviously[1].
HDAC-IN-36 (0-10, 24 h) induces noteworthy autophagy, increases the expression of Beclin1, LC3II and decreases the expression of SQSTM1/p62[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

HDAC-IN-36 Related Antibodies

Cell Viability Assay

Cell Line: MDA-MB-231 cells[1]
Concentration: 0, 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Exhibited good anti-proliferative activity in MDA-MB-231 cells, with IC50 of 1.32 ± 0.13 μM, increased the acetylation level of intracellular proteins, and promoted the acetylation of α-Tubulin and HSP90.

Apoptosis Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 0, 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Induced apoptosis in MDA-MB-231 cells in a dose-dependent manner.

Cell Autophagy Assay

Cell Line: MDA-MB-231 cells[1]
Concentration: 0, 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Induced noteworthy autophagy with increased aggregation of LC3 puncta.

Western Blot Analysis

Cell Line: MDA-MB-231 cells[1]
Concentration: 0, 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Mainly induced mitochondrial-dependent apoptosis, up-regulated the expression of Bax and downregulated the expression of Bcl-2, and increased the cleavage of caspase3, caspase8 and caspase9; increased the expression of E-cadherin and decreased the expression of MMP-2 obviously; increased the expression of Beclin1, LC3II and decreased the expression of SQSTM1/p62.
In Vivo

HDAC-IN-36 (compound 23 g) (Zebrafish tumor xenograft model; 0-5 μg/mL, 3 days) shows potent anti-tumor and anti-metastatic activity, and improves in vivo anti-tumor efficacy[1].
HDAC-IN-36 (Beagles, 20 mg/kg, Orally, once) shows a significant improvement in pharmacokinetic parameters[1].
Pharmacokinetic Parameters of HDAC-IN-36 in male Beagles[1].

Parameters 23g (20 mg/kg)
T1/2 (h) 1.24 ± 0.21
Tmax (h) 0.79 ± 0.33
Cmax (μg/L) 120.36 ± 15.53
AUC0-t (μg/L∗h) 1275.35 ± 70.17
AUC0-∞ (μg/L∗h) 1289.40 ± 88.91

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Zebrafish (MDA-MB-231-derived xenograft model, Wild-type AB strain)[1]
Dosage: 0, 2.5, 5 μg/mL
Administration: 3 days
Result: Inhibited tumor formation and migration in a dose-dependent manner, and improved in vivo anti-tumor efficacy.
Animal Model: Beagles (female, 8-10 kg, n = 4)[1]
Dosage: 20 mg/kg (dissolved 0.5% sodium carboxyl methyl cellulose (CMC-Na) aqueous solution)
Administration: Orally, once (Pharmacokinetic Analysis)
Result: Showed a significant improvement in pharmacokinetic parameters with T1/2 value of 1.24 h.
Molecular Weight

537.65

Formula

C29H39N5O5
CAS No.
SMILES

COC1=CC(OC)=C2C(N=C(N=C2N3CCN(CC3)C)C4=CC(C)=C(C(C)=C4)OCCCCCC(NO)=O)=C1
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

HDAC-IN-36 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

HDAC-IN-362482992-54-9HDACAutophagyApoptosisHistone deacetylasesBreast cancerOrally activeMDA-MB-231 cellAnti-tumor activityInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
HDAC-IN-36
Cat. No.:
HY-146684
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.